Mustafa Beneklı

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival

Mustafa Beneklı, Zheng Xia, Kathleen Donohue et al. · Blood · 2002 · 176 citations · Full text

Life Sciences, Molecular Biology, Oncology +13

Prognostic significance of <i>MYC</i>, <i>BCL2</i>, and <i>BCL6</i> rearrangements in patients with diffuse large B‐cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab

Nalân Akyürek, Ayşegül Üner, Mustafa Beneklı et al. · Cancer · 2011 · 159 citations · Full text

Medicine, Oncology, Pathology +16

The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet's disease. A randomized clinical trial

Meral Çalgünerı, Sedat Kiraz, İhsan Ertenli et al. · Arthritis & Rheumatism · 1996 · 121 citations

Life Sciences, Immunology, Pharmacotherapy +13

Prognostic factors in critically ill cancer patients admitted to the intensive care unit

Gülbin Aygencel, Melda Türkoğlu, Gülsan Türköz Sucak et al. · Journal of Critical Care · 2014 · 103 citations

Medicine, Oncology, Critical Care Medicine +11